Analysts Viewpoint
Short interest on COLL sees a significant increase on 2025-08-29
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Collegium Pharmaceutical
Menu
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Collegium Pharmaceutical
Collegium Pharmaceutical Inc’s recently made public that its EVP and Chief Medical Officer Smith Thomas B unloaded Company’s shares for
Collegium Pharmaceutical Inc’s filing revealed that its EVP and Chief Medical Officer Smith Thomas B unloaded Company’s shares for reported
In a filing, Collegium Pharmaceutical Inc revealed its Officer Smith Thomas B acquired Company’s shares for reported $0.67 million on
Collegium Pharmaceutical Inc’s recent filing unveils that its Former Director Heffernan Michael Thomas acquired Company’s shares for reported $0.33 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Collegium Pharmaceutical
In a filing, Collegium Pharmaceutical Inc revealed its Former Director Heffernan Michael Thomas acquired Company’s shares for reported $0.33 million
Collegium Pharmaceutical Inc’s filing revealed that its Former Director Heffernan Michael Thomas acquired Company’s shares for reported $0.33 million on